Ken Fisher's TVTX Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 15,849 shares of Travere Therapeutics, Inc. (TVTX) worth $900,401, representing 0.00% of the portfolio. First purchased in 2020-Q4, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in TVTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 22,327 shares. Largest reduction occurred in Q2 2026, reducing 18,147 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Travere Therapeutics (TVTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Travere Therapeutics (TVTX) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -18,147 | Reduce 53.38% | 15,849 | $56.81 |
| Q4 2025 | -5,345 | Reduce 13.59% | 33,996 | $38.21 |
| Q3 2025 | -3,841 | Reduce 8.89% | 39,341 | $23.90 |
| Q1 2023 | -15,691 | Reduce 26.65% | 43,182 | $22.49 |
| Q4 2022 | -7,489 | Reduce 11.29% | 58,873 | $21.03 |
| Q2 2022 | -83 | Reduce 0.12% | 66,362 | $24.23 |
| Q1 2022 | +22,327 | Add 50.61% | 66,445 | $25.77 |
| Q4 2021 | +15,938 | Add 56.56% | 44,118 | $31.03 |
| Q3 2021 | +6,110 | Add 27.68% | 28,180 | $24.24 |
| Q4 2020 | +22,070 | New Buy | 22,070 | $27.28 |
Ken Fisher's Travere Therapeutics Investment FAQs
Ken Fisher first purchased Travere Therapeutics, Inc. (TVTX) in Q4 2020, acquiring 22,070 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Travere Therapeutics, Inc. (TVTX) for 23 quarters since Q4 2020.
Ken Fisher's largest addition to Travere Therapeutics, Inc. (TVTX) was in Q1 2022, adding 66,445 shares worth $1.71 M.
According to the latest 13F filing for Q2 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 15,849 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $900,401.
As of the Q2 2026 filing, Travere Therapeutics, Inc. (TVTX) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Travere Therapeutics, Inc. (TVTX) was 66,445 shares, as reported at the end of Q1 2022.